Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans for NSE and BSE Stocks

Quarter

Conference/Earnings Calls Alerts

Hindalco Industries Ltd.

26 May 2025

649.60

1.22%

Earnings Call

Hindalco Industries Ltd - 500440 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith transcript of Earning Conference call held on May 20, 2025, for the financial results of quarter and financial year ended March 31, 2025.

pdf

Rainbow Childrens Medicare Ltd.

26 May 2025

1450.40

2.03%

Rainbow Childrens Medicare Results Earnings Call for Q4FY25 & Full Year

Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Healthcare Global Enterprises Ltd.

26 May 2025

549.70

0.37%

Healthcare Global Enterprises Results Earnings Call for Q4FY25 & Full Year

Conference Call with Healthcare Global Enterprises Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Cello World Ltd.

26 May 2025

606.60

1.02%

Cello World Results Earnings Call for Q4FY25 & Full Year

Conference Call with Cello World Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Eris Lifesciences Ltd.

26 May 2025

1847.70

2.93%

Earnings Call

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Earnings call transcript

pdf

Hindustan Media Ventures Ltd.

26 May 2025

88.00

0.13%

Earnings Call

Hindustan Media Ventures Ltd - 533217 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed Transcript of Conference Call for Analysts and Investors meet

pdf

Glenmark Pharmaceuticals Ltd.

26 May 2025

1683.40

0.81%

Glenmark Pharmaceuticals Results Earnings Call for Q4FY25 & Full Year

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio